Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
7.77
-0.02 (-0.19%)
At close: Sep 5, 2025, 4:00 PM
7.92
+0.16 (2.00%)
After-hours: Sep 5, 2025, 6:58 PM EDT
Jade Biosciences Market Cap
Jade Biosciences has a market cap or net worth of $253.51 million as of September 5, 2025.
Market Cap
253.51M
Enterprise Value
291.72M
1-Year Change
n/a
Ranking
Category
Stock Price
$7.77
Market Cap Chart
Since April 29, 2025, Jade Biosciences's market cap has decreased from $326.87M to $253.51M, a decrease of -22.44%. That is a compound annual growth rate of -51.28%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 5, 2025 | 253.51M | -0.13% |
Sep 4, 2025 | 253.84M | 3.80% |
Sep 3, 2025 | 244.54M | -1.64% |
Sep 2, 2025 | 248.62M | -3.54% |
Aug 29, 2025 | 257.75M | -2.23% |
Aug 28, 2025 | 263.62M | 1.64% |
Aug 27, 2025 | 259.38M | -1.00% |
Aug 26, 2025 | 261.99M | 1.65% |
Aug 25, 2025 | 257.75M | -4.01% |
Aug 22, 2025 | 268.52M | 11.52% |
Aug 21, 2025 | 240.79M | 7.74% |
Aug 20, 2025 | 223.49M | -6.93% |
Aug 19, 2025 | 240.13M | -1.87% |
Aug 18, 2025 | 244.70M | 1.90% |
Aug 15, 2025 | 240.13M | 8.71% |
Aug 14, 2025 | 220.88M | -7.64% |
Aug 13, 2025 | 239.15M | 0.39% |
Aug 12, 2025 | 238.22M | -0.14% |
Aug 11, 2025 | 238.55M | -1.20% |
Aug 8, 2025 | 241.45M | 2.32% |
Aug 7, 2025 | 235.97M | -6.51% |
Aug 6, 2025 | 252.41M | -1.39% |
Aug 5, 2025 | 255.95M | 8.92% |
Aug 4, 2025 | 235.00M | 5.81% |
Aug 1, 2025 | 222.11M | -4.17% |
Jul 31, 2025 | 231.78M | 4.51% |
Jul 30, 2025 | 221.78M | -8.63% |
Jul 29, 2025 | 242.74M | -2.84% |
Jul 28, 2025 | 249.83M | -6.40% |
Jul 25, 2025 | 266.91M | -0.60% |
Jul 24, 2025 | 268.53M | -4.36% |
Jul 23, 2025 | 280.77M | -3.01% |
Jul 22, 2025 | 289.48M | 3.34% |
Jul 21, 2025 | 280.13M | -8.24% |
Jul 18, 2025 | 305.27M | -0.42% |
Jul 17, 2025 | 306.56M | 7.95% |
Jul 16, 2025 | 284.00M | 2.68% |
Jul 15, 2025 | 276.58M | -4.67% |
Jul 14, 2025 | 290.12M | -8.35% |
Jul 11, 2025 | 316.56M | -6.65% |
Jul 10, 2025 | 339.12M | 0.10% |
Jul 9, 2025 | 338.80M | 0.29% |
Jul 8, 2025 | 337.83M | 0.29% |
Jul 7, 2025 | 336.87M | -6.19% |
Jul 3, 2025 | 359.11M | 3.15% |
Jul 2, 2025 | 348.15M | -0.41% |
Jul 1, 2025 | 349.60M | 8.56% |
Jun 30, 2025 | 322.04M | 8.71% |
Jun 27, 2025 | 296.25M | -0.65% |
Jun 26, 2025 | 298.18M | -11.99% |
Jun 25, 2025 | 338.80M | 0.29% |
Jun 24, 2025 | 337.83M | 6.18% |
Jun 23, 2025 | 318.17M | -0.20% |
Jun 20, 2025 | 318.81M | 5.10% |
Jun 18, 2025 | 303.34M | 13.51% |
Jun 17, 2025 | 267.24M | 18.60% |
Jun 16, 2025 | 225.33M | 3.40% |
Jun 13, 2025 | 217.91M | -2.59% |
Jun 12, 2025 | 223.72M | -1.28% |
Jun 11, 2025 | 226.62M | -0.42% |
Jun 10, 2025 | 227.59M | -8.43% |
Jun 9, 2025 | 248.54M | 7.23% |
Jun 6, 2025 | 231.78M | 4.35% |
Jun 5, 2025 | 222.11M | -4.44% |
Jun 4, 2025 | 232.42M | -0.55% |
Jun 3, 2025 | 233.71M | 0.69% |
Jun 2, 2025 | 232.10M | -0.69% |
May 30, 2025 | 233.71M | 2.26% |
May 29, 2025 | 228.55M | -2.21% |
May 28, 2025 | 233.71M | -1.63% |
May 27, 2025 | 237.58M | 4.84% |
May 23, 2025 | 226.62M | -3.96% |
May 22, 2025 | 235.97M | -2.27% |
May 21, 2025 | 241.45M | -2.92% |
May 20, 2025 | 248.70M | 3.98% |
May 19, 2025 | 239.19M | 1.02% |
May 16, 2025 | 236.77M | -0.74% |
May 15, 2025 | 238.55M | -1.99% |
May 14, 2025 | 243.38M | -12.31% |
May 13, 2025 | 277.55M | 0.35% |
May 12, 2025 | 276.58M | -0.81% |
May 9, 2025 | 278.84M | -3.89% |
May 8, 2025 | 290.12M | -2.81% |
May 7, 2025 | 298.50M | -8.23% |
May 6, 2025 | 325.26M | -12.26% |
May 5, 2025 | 370.71M | -7.85% |
May 2, 2025 | 402.30M | 24.80% |
May 1, 2025 | 322.36M | 5.26% |
Apr 30, 2025 | 306.24M | -6.31% |
Apr 29, 2025 | 326.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 662.38B |
Johnson & Johnson | 428.68B |
AbbVie | 374.26B |
UnitedHealth Group | 278.84B |
AstraZeneca | 254.65B |
Novo Nordisk | 253.55B |
Novartis AG | 248.54B |
Abbott Laboratories | 230.05B |